DDInter1066 DDInter1620
Ever since its discovery and availability for sale and use in the late 1940s, lidocaine has become an exceptionally commonly used medication. In particular, lidocaine's principal mode of action in acting as a local anesthetic that numbs the sensations of tissues means the agent is indicated for facilitating local anesthesia for a large variety of surgical procedures [F4349, L5930, L5948]. It ultimately elicits its numbing activity by blocking sodium channels so that the neurons of local tissues that have the medication applied on are transiently incapable of signaling the brain regarding sensations [F4349, L5930, L5948]. In doing so, however, it can block or decrease muscle contractile, resulting in effects like vasodilation, hypotension, and irregular heart rate, among others [F4349, L5930, L5948]. As a result, lidocaine is also considered a class Ib anti-arrhythmic agent [L
Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Lidocaine {u} (Compound) resembles {v} (Compound) Ropivacaine
Lidocaine {u} (Compound) resembles {v} (Compound) Levobupivacaine
Levobupivacaine {u} (Compound) resembles {v} (Compound) Ropivacaine
Lidocaine {u} (Compound) resembles {v} (Compound) Bupivacaine
Bupivacaine {u} (Compound) resembles {v} (Compound) Ropivacaine
Lidocaine {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Tocainide
Tocainide {u} (Compound) resembles {v} (Compound) Ropivacaine
Lidocaine {u} (Compound) binds {v} (Gene) SCN10A
SCN10A {u} (Gene) is bound by {v} (Compound) Ropivacaine
Lidocaine {u} (Compound) is included by {v} (Pharmacologic Class) Amides
Amides {u} (Pharmacologic Class) includes {v} (Compound) Ropivacaine
Lidocaine {u} (Compound) causes {v} (Side Effect) Ventricular tachycardia
Ventricular tachycardia {u} (Side Effect) is caused by {v} (Compound) Ropivacaine
Lidocaine {u} (Compound) resembles {v} (Compound) Levobupivacaine
Levobupivacaine {u} (Compound) resembles {v} (Compound) Bupivacaine
Bupivacaine {u} (Compound) resembles {v} (Compound) Ropivacaine
Lidocaine {u} (Compound) resembles {v} (Compound) Bupivacaine
Bupivacaine {u} (Compound) resembles {v} (Compound) Levobupivacaine
Levobupivacaine {u} (Compound) resembles {v} (Compound) Ropivacaine
Lidocaine {u} (Compound) resembles {v} (Compound) Mepivacaine
Mepivacaine {u} (Compound) resembles {v} (Compound) Levobupivacaine
Levobupivacaine {u} (Compound) resembles {v} (Compound) Ropivacaine
Lidocaine (Compound) resembles Ropivacaine (Compound)
Lidocaine (Compound) resembles Levobupivacaine (Compound) and Levobupivacaine (Compound) resembles Ropivacaine (Compound)
Lidocaine (Compound) resembles Bupivacaine (Compound) and Bupivacaine (Compound) resembles Ropivacaine (Compound)
Lidocaine (Compound) resembles Tocainide (Compound) and Lidocaine may cause a moderate interaction that could exacerbate diseases when taken with Tocainide and Tocainide (Compound) resembles Ropivacaine (Compound)
Lidocaine (Compound) binds SCN10A (Gene) and SCN10A (Gene) is bound by Ropivacaine (Compound)
Lidocaine (Compound) is included by Amides (Pharmacologic Class) and Amides (Pharmacologic Class) includes Ropivacaine (Compound)
Lidocaine (Compound) causes Ventricular tachycardia (Side Effect) and Ventricular tachycardia (Side Effect) is caused by Ropivacaine (Compound)
Lidocaine (Compound) resembles Levobupivacaine (Compound) and Levobupivacaine (Compound) resembles Bupivacaine (Compound) and Bupivacaine (Compound) resembles Ropivacaine (Compound)
Lidocaine (Compound) resembles Bupivacaine (Compound) and Bupivacaine (Compound) resembles Levobupivacaine (Compound) and Levobupivacaine (Compound) resembles Ropivacaine (Compound)
Lidocaine (Compound) resembles Mepivacaine (Compound) and Mepivacaine (Compound) resembles Levobupivacaine (Compound) and Levobupivacaine (Compound) resembles Ropivacaine (Compound)